Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors

Ping Wu, Yumei Ye, C. N. Svendsen

Research output: Contribution to journalArticle

46 Citations (Scopus)

Abstract

Human neural progenitor cells (hNPCs) represent an attractive source for cell therapy of neurological disorders. Genetic modification of hNPCs may allow a controlled release of therapeutic proteins, suppress immune rejection, or produce essential neurotransmitters. In search of an effective gene delivery vehicle, we evaluated the efficiency of a recombinant adeno-associated viral (rAAV) vector expressing enhanced green fluorescent protein (CAGegfp). Our study demonstrated that CAGegfp efficiently transduced both proliferating and differentiated hNPCs in vitro. EGFP expression was detected as early as 1 day after exposure to CAGegfp and was detectable for up to 4 months. Following transduction, the growth rate of hNPCs slowed down, but they were still able to differentiate into neurons and glia. Furthermore, CAGegfp-modified hNPCs survived, differentiated and expressed EGFP after transplanting into spinal cord of adult rats. Our results indicated that rAAV vectors might be a useful tool in hNPC-based cell and gene therapy for neurological disorders.

Original languageEnglish (US)
Pages (from-to)245-255
Number of pages11
JournalGene Therapy
Volume9
Issue number4
DOIs
StatePublished - Jan 1 2002

Fingerprint

Stem Cells
Cell- and Tissue-Based Therapy
Nervous System Diseases
Medical Genetics
Neuroglia
Genetic Therapy
Neurotransmitter Agents
Spinal Cord
Neurons
Growth
Genes
Proteins
Therapeutics

Keywords

  • Adeno-associated virus
  • Green fluorescent protein
  • Human neural progenitor cells
  • Rat
  • Spinal cord
  • Transplantation

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors. / Wu, Ping; Ye, Yumei; Svendsen, C. N.

In: Gene Therapy, Vol. 9, No. 4, 01.01.2002, p. 245-255.

Research output: Contribution to journalArticle

@article{94af013bc91649f0a56afea4d6f755eb,
title = "Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors",
abstract = "Human neural progenitor cells (hNPCs) represent an attractive source for cell therapy of neurological disorders. Genetic modification of hNPCs may allow a controlled release of therapeutic proteins, suppress immune rejection, or produce essential neurotransmitters. In search of an effective gene delivery vehicle, we evaluated the efficiency of a recombinant adeno-associated viral (rAAV) vector expressing enhanced green fluorescent protein (CAGegfp). Our study demonstrated that CAGegfp efficiently transduced both proliferating and differentiated hNPCs in vitro. EGFP expression was detected as early as 1 day after exposure to CAGegfp and was detectable for up to 4 months. Following transduction, the growth rate of hNPCs slowed down, but they were still able to differentiate into neurons and glia. Furthermore, CAGegfp-modified hNPCs survived, differentiated and expressed EGFP after transplanting into spinal cord of adult rats. Our results indicated that rAAV vectors might be a useful tool in hNPC-based cell and gene therapy for neurological disorders.",
keywords = "Adeno-associated virus, Green fluorescent protein, Human neural progenitor cells, Rat, Spinal cord, Transplantation",
author = "Ping Wu and Yumei Ye and Svendsen, {C. N.}",
year = "2002",
month = "1",
day = "1",
doi = "10.1038/sj.gt.3301646",
language = "English (US)",
volume = "9",
pages = "245--255",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Transduction of human neural progenitor cells using recombinant adeno-associated viral vectors

AU - Wu, Ping

AU - Ye, Yumei

AU - Svendsen, C. N.

PY - 2002/1/1

Y1 - 2002/1/1

N2 - Human neural progenitor cells (hNPCs) represent an attractive source for cell therapy of neurological disorders. Genetic modification of hNPCs may allow a controlled release of therapeutic proteins, suppress immune rejection, or produce essential neurotransmitters. In search of an effective gene delivery vehicle, we evaluated the efficiency of a recombinant adeno-associated viral (rAAV) vector expressing enhanced green fluorescent protein (CAGegfp). Our study demonstrated that CAGegfp efficiently transduced both proliferating and differentiated hNPCs in vitro. EGFP expression was detected as early as 1 day after exposure to CAGegfp and was detectable for up to 4 months. Following transduction, the growth rate of hNPCs slowed down, but they were still able to differentiate into neurons and glia. Furthermore, CAGegfp-modified hNPCs survived, differentiated and expressed EGFP after transplanting into spinal cord of adult rats. Our results indicated that rAAV vectors might be a useful tool in hNPC-based cell and gene therapy for neurological disorders.

AB - Human neural progenitor cells (hNPCs) represent an attractive source for cell therapy of neurological disorders. Genetic modification of hNPCs may allow a controlled release of therapeutic proteins, suppress immune rejection, or produce essential neurotransmitters. In search of an effective gene delivery vehicle, we evaluated the efficiency of a recombinant adeno-associated viral (rAAV) vector expressing enhanced green fluorescent protein (CAGegfp). Our study demonstrated that CAGegfp efficiently transduced both proliferating and differentiated hNPCs in vitro. EGFP expression was detected as early as 1 day after exposure to CAGegfp and was detectable for up to 4 months. Following transduction, the growth rate of hNPCs slowed down, but they were still able to differentiate into neurons and glia. Furthermore, CAGegfp-modified hNPCs survived, differentiated and expressed EGFP after transplanting into spinal cord of adult rats. Our results indicated that rAAV vectors might be a useful tool in hNPC-based cell and gene therapy for neurological disorders.

KW - Adeno-associated virus

KW - Green fluorescent protein

KW - Human neural progenitor cells

KW - Rat

KW - Spinal cord

KW - Transplantation

UR - http://www.scopus.com/inward/record.url?scp=85047696085&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047696085&partnerID=8YFLogxK

U2 - 10.1038/sj.gt.3301646

DO - 10.1038/sj.gt.3301646

M3 - Article

VL - 9

SP - 245

EP - 255

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 4

ER -